Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome
Clinical trial NCT05605665 · COMPLETED
Trial details
- NCT number
- NCT05605665
- Sponsor
- Peking University People's Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-05
- Primary completion
- 2023-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.